S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Dutch firm: US, allies near deal to limit chip tech to China
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Dutch firm: US, allies near deal to limit chip tech to China
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Dutch firm: US, allies near deal to limit chip tech to China
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Dutch firm: US, allies near deal to limit chip tech to China
NASDAQ:JAGX

Jaguar Health - JAGX Stock Forecast, Price & News

$4.70
+0.19 (+4.21%)
(As of 01/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$4.45
▼
$4.77
50-Day Range
$0.08
▼
$5.43
52-Week Range
$4.45
▼
$66.75
Volume
311,528 shs
Average Volume
381,650 shs
Market Capitalization
$9.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Jaguar Health MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
9.07% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.58mentions of Jaguar Health in the last 14 days
Based on 9 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($48.50) to ($27.07) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.60 out of 5 stars

See Top Rated MarketRank™ Stocks Here

JAGX stock logo

About Jaguar Health (NASDAQ:JAGX) Stock

Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. The firm focuses on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. It operates through the Human Health and Animal Health segments. The Human Health segment manufactures human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment commercializes prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.

Receive JAGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Jaguar Health and its competitors with MarketBeat's FREE daily newsletter.

JAGX Stock News Headlines

January 26, 2023 | finanznachrichten.de
Jaguar Health, Inc.: Jaguar Health Provides Updates Regarding Company's Focus on Rare and Orphan Disease Indications in the U.S. & Europe
January 26, 2023 | finance.yahoo.com
Jaguar Health Provides Updates Regarding Company's Focus on Rare and Orphan Disease Indications in the U.S. & Europe
January 29, 2023 | Porter & Company (Ad)
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
January 25, 2023 | finance.yahoo.com
Jaguar Health Announces Completion of Key Milestone in Process of Establishing Indena S.p.A. as a Reliable Approved Crofelemer Manufacturer
January 25, 2023 | americanbankingnews.com
Jaguar Health (NASDAQ:JAGX) Reaches New 52-Week Low at $6.00
January 25, 2023 | americanbankingnews.com
Jaguar Health (NASDAQ:JAGX) Now Covered by StockNews.com
January 23, 2023 | investorplace.com
Is Jaguar Health (JAGX) Stock Really Up 6,800%?
January 23, 2023 | finanznachrichten.de
Jaguar Health, Inc.: Jaguar Health Announces Establishment of Board of Directors for Newly Formed Joint Venture Magdalena Biosciences
January 29, 2023 | Porter & Company (Ad)
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
January 23, 2023 | americanbankingnews.com
Jaguar Health, Inc. (NASDAQ:JAGX) Short Interest Down 13.5% in December
January 20, 2023 | finanznachrichten.de
Jaguar Health, Inc.: Jaguar Health to Present at Lytham Partners Investor Select Conference on January 31st
January 20, 2023 | finanznachrichten.de
Jaguar Health, Inc.: Jaguar Health Reports Voting Results from January 2023 Special Meeting of Stockholders
January 20, 2023 | finance.yahoo.com
Jaguar Health to Present at Lytham Partners Investor Select Conference on January 31st
January 20, 2023 | finance.yahoo.com
Jaguar Health Reports Voting Results from January 2023 Special Meeting of Stockholders
January 14, 2023 | benzinga.com
REMINDER: Jaguar Health to Hold Investor Webcast...
January 11, 2023 | finance.yahoo.com
REMINDER: Jaguar Health to Hold Investor Webcast Thursday, January 12th at 10:30 AM EST to Highlight Unmet Medical Need of Cancer Therapy-related Diarrhea and Jaguar’s Mental Health Entheogen Therapeutics Initiative (ETI) to Discover Novel Therapies Derived from Psychoactive Plants
January 10, 2023 | msn.com
6 Psychedelics Companies Take Action: Here Are The Latest, Major Announcements
January 10, 2023 | markets.businessinsider.com
Jaguar Health's JV To Develop Botanical Pharmaceutical Drug Candidates For Mental Health Illnesses
January 10, 2023 | finance.yahoo.com
Jaguar Health and Filament Health, with Funding from One Small Planet, Form Joint Venture Magdalena Biosciences to Develop Botanical Pharmaceutical Drug Candidates for Mental Health Illnesses
January 10, 2023 | finance.yahoo.com
Jaguar Health to Hold Investor Webcast Thursday, January 12th at 10:30 AM EST to Highlight Unmet Medical Need of Cancer Therapy-related Diarrhea and Jaguar's Mental Health Entheogen Therapeutics Initiative (ETI) to Discover Novel Therapies Derived from Psychoactive Plants
December 19, 2022 | finance.yahoo.com
Jaguar Health Provides Updates on Presentation at the World Congress of Gastroenterology About Crofelemer for Pediatric Short Bowel Syndrome (SBS) and Congenital Diarrheal Disorders (CDD) by Third-Party Investigator
December 5, 2022 | finanznachrichten.de
Jaguar Health, Inc.: Jaguar Health Subsidiary Napo Pharmaceuticals Sponsors Episode of The Gayly Dose Focused on HIV-related Diarrhea
December 5, 2022 | finance.yahoo.com
Jaguar Health Subsidiary Napo Pharmaceuticals Sponsors Episode of The Gayly Dose Focused on HIV-related Diarrhea
November 21, 2022 | finanznachrichten.de
Jaguar Health, Inc.: Jaguar Health Hosts Symposium on the Management of Cancer Therapy-related Diarrhea
November 21, 2022 | finance.yahoo.com
Jaguar Health Hosts Symposium on the Management of Cancer Therapy-related Diarrhea
November 14, 2022 | finanznachrichten.de
Jaguar Health, Inc.: Jaguar Health Provides Company Updates and Reports 2022 Third Quarter Financials
November 14, 2022 | finance.yahoo.com
Jaguar Health Provides Company Updates and Reports 2022 Third Quarter Financials
See More Headlines
Receive JAGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Jaguar Health and its competitors with MarketBeat's FREE daily newsletter.

JAGX Company Calendar

Last Earnings
11/14/2022
Today
1/29/2023
Next Earnings (Estimated)
3/10/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:JAGX
CUSIP
N/A
CIK
1585608
Web
www.jaguaranimalhealth.com
Phone
(415) 371-8300
Fax
N/A
Employees
52
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($71.4286)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-52,600,000.00
Net Margins
-502.84%
Pretax Margin
-505.58%
Return on Equity
-823.56%
Return on Assets
-104.53%

Debt

Debt-to-Equity Ratio
5.56
Current Ratio
0.94
Quick Ratio
0.69

Sales & Book Value

Annual Sales
$4.34 million
Price / Sales
2.09
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$17.66 per share
Price / Book
0.27

Miscellaneous

Outstanding Shares
1,930,000
Free Float
1,913,000
Market Cap
$9.07 million
Optionable
Not Optionable
Beta
1.73

Key Executives

  • Lisa A. Conte
    President, Chief Executive Officer & Director
  • Carol R. Lizak
    Chief Financial Officer
  • Pravin Ramsewak Chaturvedi
    Chief Scientific Officer
  • Jonathan S. Wolin
    Chief of Staff & Chief Compliance Officer
  • Karen J. Brunke
    Executive VP-Corporate & Business Development

Key Competitors

View All Competitors

Insiders & Institutions

View All Institutional Transactions













JAGX Stock - Frequently Asked Questions

How have JAGX shares performed in 2023?

Jaguar Health's stock was trading at $0.0869 at the beginning of the year. Since then, JAGX shares have increased by 5,308.5% and is now trading at $4.70.
View the best growth stocks for 2023 here.

When is Jaguar Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, March 10th 2023.
View our JAGX earnings forecast.

How were Jaguar Health's earnings last quarter?

Jaguar Health, Inc. (NASDAQ:JAGX) issued its earnings results on Monday, November, 14th. The biotechnology company reported ($0.12) earnings per share for the quarter. The biotechnology company earned $3.15 million during the quarter. Jaguar Health had a negative trailing twelve-month return on equity of 823.56% and a negative net margin of 502.84%.

When did Jaguar Health's stock split?

Jaguar Health's stock reverse split on Wednesday, September 8th 2021. The 1-3 reverse split was announced on Wednesday, September 8th 2021. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, September 8th 2021. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.

What other stocks do shareholders of Jaguar Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Jaguar Health investors own include Biocept (BIOC), Sorrento Therapeutics (SRNE), Trevena (TRVN), Vaxart (VXRT), Purple Biotech (KTOV), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Biopharmx (BPMX), Cara Therapeutics (CARA) and Conatus Pharmaceuticals (CNAT).

When did Jaguar Health IPO?

(JAGX) raised $22 million in an initial public offering on Wednesday, May 13th 2015. The company issued 3,200,000 shares at a price of $7.00 per share. Aegis Capital Corp acted as the underwriter for the IPO and CRT Capital and Feltl and Company were co-managers.

What is Jaguar Health's stock symbol?

Jaguar Health trades on the NASDAQ under the ticker symbol "JAGX."

How do I buy shares of Jaguar Health?

Shares of JAGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Jaguar Health's stock price today?

One share of JAGX stock can currently be purchased for approximately $4.70.

How much money does Jaguar Health make?

Jaguar Health (NASDAQ:JAGX) has a market capitalization of $9.07 million and generates $4.34 million in revenue each year. The biotechnology company earns $-52,600,000.00 in net income (profit) each year or ($71.4286) on an earnings per share basis.

How can I contact Jaguar Health?

Jaguar Health's mailing address is 201 MISSION STREET SUITE 2375, SAN FRANCISCO CA, 94105. The official website for the company is www.jaguaranimalhealth.com. The biotechnology company can be reached via phone at (415) 371-8300.

This page (NASDAQ:JAGX) was last updated on 1/29/2023 by MarketBeat.com Staff